TG
ELV icon

TCW Group’s Elevance Health ELV Stock Holding History

TCW Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Sell
3,668
-1,202
-25% -$395K 0.01% 356
2025
Q4 		$1.71M Buy
+4,870
New +$1.65M 0.01% 295
2025
Q3 		– Sell
-14,411
Closed -$5.61M – 282
2025
Q2 		$5.61M Sell
14,411
-810
-5% -$326K 0.04% 170
2025
Q1 		$6.62M Sell
15,221
-45,208
-75% -$18.1M 0.06% 163
2024
Q4 		$22.3M Sell
60,429
-41,211
-41% -$17.2M 0.19% 95
2024
Q3 		$52.9M Buy
101,640
+42,464
+72% +$22.7M 0.46% 61
2024
Q2 		$32.1M Buy
59,176
+8,321
+16% +$4.4M 0.29% 79
2024
Q1 		$26.4M Sell
50,855
-859
-2% -$427K 0.27% 85
2023
Q4 		$24.4M Buy
51,714
+6,351
+14% +$2.94M 0.27% 80
2023
Q3 		$19.8M Sell
45,363
-2,251
-5% -$1.02M 0.25% 84
2023
Q2 		$21.2M Sell
47,614
-3,485
-7% -$1.61M 0.23% 85
2023
Q1 		$23.5M Buy
51,099
+1,113
+2% +$530K 0.3% 82
2022
Q4 		$25.6M Sell
49,986
-1,961
-4% -$996K 0.37% 67
2022
Q3 		$23.6M Buy
51,947
+466
+0.9% +$223K 0.35% 69
2022
Q2 		$24.8M Buy
51,481
+7
+0% +$3.46K 0.33% 74
2022
Q1 		$25.3M Buy
51,474
+3,937
+8% +$1.8M 0.24% 90
2021
Q4 		$22M Buy
47,537
+34,224
+257% +$14.4M 0.18% 104
2021
Q3 		$4.96K Buy
13,313
+692
+5% +$263K 0.01% 198
2021
Q2 		$4.82M Sell
12,621
-194
-2% -$74.1K 0.04% 207
2021
Q1 		$4.6M Buy
+12,815
New +$4.12M 0.04% 203
2017
Q4 		– Sell
-325,340
Closed -$61.8M – 380
2017
Q3 		$61.8M Sell
325,340
-25,058
-7% -$4.77M 0.49% 71
2017
Q2 		$65.9M Sell
350,398
-47,375
-12% -$8.51M 0.55% 63
2017
Q1 		$65.8M Sell
397,773
-68,413
-15% -$10.9M 0.55% 69
2016
Q4 		$67M Sell
466,186
-459,881
-50% -$61.6M 0.5% 66
2016
Q3 		$116M Sell
926,067
-52,157
-5% -$6.73M 0.88% 45
2016
Q2 		$128M Sell
978,224
-56,879
-5% -$7.78M 0.97% 37
2016
Q1 		$144M Buy
1,035,103
+117,033
+13% +$15.6M 1.06% 33
2015
Q4 		$128M Buy
918,070
+20,249
+2% +$2.79M 0.92% 42
2015
Q3 		$126M Buy
897,821
+51,591
+6% +$7.75M 0.9% 44
2015
Q2 		$139M Sell
846,230
-156,279
-16% -$25M 0.89% 43
2015
Q1 		$155M Sell
1,002,509
-119,779
-11% -$17.1M 0.74% 46
2014
Q4 		$141M Sell
1,122,288
-48,570
-4% -$6M 0.59% 60
2014
Q3 		$140M Buy
1,170,858
+119,244
+11% +$13.7M 0.56% 54
2014
Q2 		$113M Buy
1,051,614
+120,380
+13% +$12.4M 0.47% 68
2014
Q1 		$92.7M Buy
931,234
+224,832
+32% +$20.3M 0.38% 80
2013
Q4 		$65.3M Buy
706,402
+5,816
+0.8% +$517K 0.28% 92
2013
Q3 		$58.6M Buy
700,586
+93,642
+15% +$8.03M 0.27% 93
2013
Q2 		$49.7M Buy
+606,944
New +$45.4M 0.24% 95

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

TCW Group's ELV Position: Q1 2026 in Review

TCW Group reduced its Elevance Health (ELV) stake by 25% in Q1 2026, selling an estimated $395K and leaving 3,668 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #356.

TCW Group first reported a position in ELV in Q2 2013 and has held it in 38 quarters since. The position peaked at $155M in Q1 2015. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • TCW Group held 3,668 shares of Elevance Health worth $1.07M as of Q1 2026.
  • TCW Group sold 1,202 Elevance Health shares in Q1 2026, an estimated $395K.
  • Elevance Health made up 0.01% of TCW Group's portfolio in Q1 2026, its #356 holding.
  • TCW Group first reported a position in Elevance Health in Q2 2013 and has held it in 38 quarters since.
  • TCW Group's Elevance Health position peaked at $155M in Q1 2015.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.